Worldwide Clinical Trials Optimizes Ulcerative Colitis Study Data Through Collaboration and Patient Centricity

Ulcerative colitis is an inflammatory bowel disease (IBD) causing inflammation and ulcers in the lining of the large intestine and rectum. Of particular concern for patients with prolonged ulcerative colitis is the risk of developing colon cancer progressively increases the longer they have the condition. Current treatments involve pharmacological agents or surgical intervention; the aim being to lessen symptoms or to trigger disease remission. Patient burden is a particular concern for researchers, so trial design should incorporate strategies for accommodating patient needs as well as study imperatives.

As experts in IMID research, the professionals at Worldwide Clinical Trials seek to understand inflammatory diseases by addressing the underlying causes of the patient’s symptoms. Through collaboration with thought leaders, academic research organizations, and patient advocacy groups, we not only keep abreast of scientific developments but also strive to understand the lived experience of our study subjects in order to accommodate their needs and facilitate compliance and retention. Our spirit of collaboration extends to our investigative sites, which we vet and train extensively so that you can be assured, wherever your data comes from, that it will meet study protocol and pass regulatory scrutiny.